This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Alzheimer’s disease (Atypical or mixed)
DOID EFO MESH SNOMED Endpoint Browser
AD_AM
Alzheimer's disease: A progressive, neurodegenerative disease characterized by loss of function and death of nerve cells in several areas of the brain leading to loss of cognitive function such as memory and language.
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
Hospital Discharge: ICD-10
F00.24*, G30.8, G30.8+F00.20
Cause of death: ICD-10
F00.24*, G30.8, G30.8+F00.20
2 out of 7 registries used, show all original rules.
2481
Check minimum number of events None
2481
Include endpoints None
2481
Remove individuals based on genotype QC
2419
AD_AM
Control definitions
Control exclude
G6_ALZHEIMER
Extra metadata
First used in FinnGen datafreeze
DF2
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Alzheimer’s disease (Atypical or mixed)
based on the number of shared cases.
Broader endpoints:
- Alzheimer’s disease (Atypical or mixed) (more control exclusions)
- Alzheimer’s disease, wide definition (more control exclusions)
- Alzheimer’s disease, wide definition
- Any dementia
- Any dementia (more control exclusions)
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2419 | 968 | 1451 |
| Unadjusted prevalence (%) | 0.59 | 0.42 | 0.80 |
| Mean age at first event (years) | 80.84 | 81.39 | 80.47 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: AD_AM – Alzheimer’s disease (Atypical or mixed)
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Alzheimer’s disease (Atypical or mixed)
↥Endpoint not on priority list, no data to show.